Latest Articles
Pete Davidson, Elsie Hewitt reach ‘joint agreement’ for coparenting 7-month-old daughter - New York Daily News
Pete Davidson, Elsie Hewitt reach ‘joint agreement’ for coparenting 7-month-old daughter New York Daily News
Published: Aug. 1, 2026, 6:32 p.m.
Karyopharm (KPTI) Shares Collapse 65% After Xpovio Fails Endometrial Cancer Trial Again - londoninsider.co.uk
Karyopharm (KPTI) Shares Collapse 65% After Xpovio Fails Endometrial Cancer Trial Again londoninsider.co.uk
Published: Aug. 1, 2026, 8:33 a.m.
H.C. Wainwright cuts Karyopharm stock rating on trial miss By Investing.com - Investing.com UK
H.C. Wainwright cuts Karyopharm stock rating on trial miss By Investing.com Investing.com UK
Published: Aug. 1, 2026, 6:38 a.m.
'I lost years waiting for endometriosis diagnosis' - AOL.com
'I lost years waiting for endometriosis diagnosis' AOL.com
Published: July 31, 2026, 11:18 p.m.
Live-Forever Nut Bryan Johnson, 48, Reveals Creepy Way He Controls Girlfriend, 30 - The Daily Beast
Live-Forever Nut Bryan Johnson, 48, Reveals Creepy Way He Controls Girlfriend, 30 The Daily Beast
Published: July 31, 2026, 8:33 p.m.
Live-Forever Nut Bryan Johnson, 48, Reveals Creepy Way He Controls Girlfriend, 30 - thelooker.thedailybeast.com
Live-Forever Nut Bryan Johnson, 48, Reveals Creepy Way He Controls Girlfriend, 30 thelooker.thedailybeast.com
Published: July 31, 2026, 8:33 p.m.
Selinexor Maintenance Misses Mark in TP53 Wild-Type Endometrial Cancer - Targeted Oncology
Selinexor Maintenance Misses Mark in TP53 Wild-Type Endometrial Cancer Targeted Oncology
Published: July 31, 2026, 8:06 p.m.
Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - OncLive
Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer OncLive
Published: July 31, 2026, 5:22 p.m.
Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - onclive.com
Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer onclive.com
Published: July 31, 2026, 5:22 p.m.
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged - TipRanks
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged TipRanks
Published: July 31, 2026, 2:09 p.m.
Link copied to clipboard!